Akebia Therapeutics (AKBA) Reports Q4 Loss of $0.99
Tweet
Share
E-mailAkebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.99), versus ($0.66) reported last year.
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lucid reports Q2 output, names new CFO and five other leaders
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
